PCN42 CABOZANTINIB VERSUS STANDARD-OF-CARE COMPARATORS: A NETWORK META-ANALYSIS OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
Abstract
Authors
J. Lister S. Pafitas J. Meng W. Wiecek E. Schmidt A. Zagorska F. Marteau